Search Results

There are 54 results for: "Steven A Julious" in Author

VIEW

  1. 1 - 20
  2. 21 - 40
  3. 41 - 54
  1. Corrections: The disagreeable behaviour of the kappa statistic

    Pharmaceutical Statistics

    Laura Flight and Steven A. Julious

    Version of Record online : 2 DEC 2016, DOI: 10.1002/pst.1795

    This article corrects:

    The disagreeable behaviour of the kappa statistic

    Vol. 14, Issue 1, 74–78, Version of Record online: 3 DEC 2014

  2. Other Phase I Trials

    An Introduction to Statistics in Early Phase Trials

    Steven A. Julious, Say Beng Tan, David Machin, Pages: 169–185, 2010

    Published Online : 25 JAN 2010, DOI: 10.1002/9780470686164.ch10

  3. Interpreting and Applying Early Phase Trial Results

    An Introduction to Statistics in Early Phase Trials

    Steven A. Julious, Say Beng Tan, David Machin, Pages: 223–230, 2010

    Published Online : 25 JAN 2010, DOI: 10.1002/9780470686164.ch14

  4. Inference and Estimation in a Changepoint Regression Problem

    Journal of the Royal Statistical Society: Series D (The Statistician)

    Volume 50, Issue 1, April 2001, Pages: 51–61, Steven A. Julious

    Version of Record online : 21 DEC 2001, DOI: 10.1111/1467-9884.00260

  5. Crossover Trial Basics

    An Introduction to Statistics in Early Phase Trials

    Steven A. Julious, Say Beng Tan, David Machin, Pages: 55–69, 2010

    Published Online : 25 JAN 2010, DOI: 10.1002/9780470686164.ch4

  6. You have free access to this content
    Front Matter

    An Introduction to Statistics in Early Phase Trials

    Steven A. Julious, Say Beng Tan, David Machin, Pages: i–iv, 2010

    Published Online : 25 JAN 2010, DOI: 10.1002/9780470686164.fmatter

  7. First-Time-into-New-Population Studies

    An Introduction to Statistics in Early Phase Trials

    Steven A. Julious, Say Beng Tan, David Machin, Pages: 125–138, 2010

    Published Online : 25 JAN 2010, DOI: 10.1002/9780470686164.ch8

  8. Phase II Trials with Toxic Therapies

    An Introduction to Statistics in Early Phase Trials

    Steven A. Julious, Say Beng Tan, David Machin, Pages: 211–222, 2010

    Published Online : 25 JAN 2010, DOI: 10.1002/9780470686164.ch13

  9. Sample Size Calculations for Clinical Trials

    An Introduction to Statistics in Early Phase Trials

    Steven A. Julious, Say Beng Tan, David Machin, Pages: 37–53, 2010

    Published Online : 25 JAN 2010, DOI: 10.1002/9780470686164.ch3

  10. Bayesian and Frequentist Methods

    An Introduction to Statistics in Early Phase Trials

    Steven A. Julious, Say Beng Tan, David Machin, Pages: 113–124, 2010

    Published Online : 25 JAN 2010, DOI: 10.1002/9780470686164.ch7

  11. Dose–Response Studies

    An Introduction to Statistics in Early Phase Trials

    Steven A. Julious, Say Beng Tan, David Machin, Pages: 197–210, 2010

    Published Online : 25 JAN 2010, DOI: 10.1002/9780470686164.ch12

  12. Introduction to Pharmacokinetics

    An Introduction to Statistics in Early Phase Trials

    Steven A. Julious, Say Beng Tan, David Machin, Pages: 13–35, 2010

    Published Online : 25 JAN 2010, DOI: 10.1002/9780470686164.ch2

  13. First Time into Man

    An Introduction to Statistics in Early Phase Trials

    Steven A. Julious, Say Beng Tan, David Machin, Pages: 87–111, 2010

    Published Online : 25 JAN 2010, DOI: 10.1002/9780470686164.ch6

  14. Go/No-Go Criteria

    An Introduction to Statistics in Early Phase Trials

    Steven A. Julious, Say Beng Tan, David Machin, Pages: 231–244, 2010

    Published Online : 25 JAN 2010, DOI: 10.1002/9780470686164.ch15

  15. Multi-Period Crossover Trials

    An Introduction to Statistics in Early Phase Trials

    Steven A. Julious, Say Beng Tan, David Machin, Pages: 71–85, 2010

    Published Online : 25 JAN 2010, DOI: 10.1002/9780470686164.ch5

  16. Bioequivalence Studies

    An Introduction to Statistics in Early Phase Trials

    Steven A. Julious, Say Beng Tan, David Machin, Pages: 139–167, 2010

    Published Online : 25 JAN 2010, DOI: 10.1002/9780470686164.ch9

  17. Time to end the non-inferiority complex?

    Pharmaceutical Statistics

    Volume 10, Issue 5, September/October 2011, Pages: 393–394, Steven A. Julious

    Version of Record online : 16 SEP 2011, DOI: 10.1002/pst.519

  18. Why do we use pooled variance analysis of variance?

    Pharmaceutical Statistics

    Volume 4, Issue 1, January/March 2005, Pages: 3–5, Steven A. Julious

    Version of Record online : 23 FEB 2005, DOI: 10.1002/pst.155

  19. Using confidence intervals around individual means to assess statistical significance between two means

    Pharmaceutical Statistics

    Volume 3, Issue 3, July/September 2004, Pages: 217–222, Steven A. Julious

    Version of Record online : 13 SEP 2004, DOI: 10.1002/pst.126

  20. Sample sizes for estimation in clinical research

    Pharmaceutical Statistics

    Volume 3, Issue 3, July/September 2004, Pages: 213–215, Steven A. Julious and Scott D. Patterson

    Version of Record online : 13 SEP 2004, DOI: 10.1002/pst.125

VIEW

  1. 1 - 20
  2. 21 - 40
  3. 41 - 54